BACKGROUND: Lidocaine has been the initial antiarrhythmic drug treatment recommended for patients with ventricular fibrillation that is resistant to conversion by defibrillator shocks. We performed a randomized trial comparing intravenous lidocaine with intravenous amiodarone as an adjunct to defibr...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!